Coronary Artery Disease
3,790
380
555
2,006
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
421 trials with published results (11%)
Research Maturity
2006 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.4%
205 terminated out of 3790 trials
90.7%
+4.1% vs benchmark
20%
746 trials in Phase 3/4
21%
421 of 2006 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2006 completed trials
Clinical Trials (3790)
AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study
CTSN Embolic Protection Trial
The Genomic Medicine at VA Study
OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI)
Effect of Two Weeks of Low-Dose Apixaban on Platelet Reactivity in Patients With Stable Coronary Artery Disease on Dual Antiplatelet Therapy (Aspirin and Clopidogrel)
Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease
Evaluate the Clinical Efficacy and Safety of Non-Compliant PTCA Balloon Dilatation Catheter
Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
pCAD-POAF 3 Year Follow-up
Impact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion
Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies
DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
Concurrent OCT and FFR-guided PCI in CAD
The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65
DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Intranasal Dexmedetomidine and Perioperative Myocardial Injury in Patients Having Percutaneous Coronary Interventions
Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications
Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease